Molecule Details
InChIKeyDZFZXPPHBWCXPQ-UHFFFAOYSA-N
Compound NameTak-593
Canonical SMILESCc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)12
Pfam Stratification Cross-Family
Avg pChEMBL7.57
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB13093
Drug NameTAK-593
CAS Number1005780-62-0
Groups investigational
ATC Codes nan
DescriptionTAK-593 has been used in trials studying the treatment of Solid Tumors.

Categories: Aza Compounds Receptors, Platelet-Derived Growth Factor, antagonists & inhibitors
Cross-references: BindingDB: 50399537 CHEMBL2180604 ChemSpider: 28669643 PubChem:24767976 PubChem:347829217 ZINC: ZINC000095579919
Target Activities (12)
Target Gene Organism Category Pfam pChEMBL Type Source
P35968 KDR Homo sapiens Human PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 9.0 IC50 ChEMBL;BindingDB
P35916 FLT4 Homo sapiens Human PF07679 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 9.0 IC50 ChEMBL;BindingDB
P17948 FLT1 Homo sapiens Human PF07679 PF00047 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 8.5 IC50 ChEMBL;BindingDB
P16234 PDGFRA Homo sapiens Human PF07679 PF25305 PF07714 8.4 IC50 ChEMBL;BindingDB
P07333 CSF1R Homo sapiens Human PF00047 PF25305 PF07714 8.0 IC50 ChEMBL;BindingDB
P09619 PDGFRB Homo sapiens Human PF00047 PF13927 PF25305 PF07714 7.9 IC50 ChEMBL;BindingDB
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 7.8 IC50 ChEMBL;BindingDB
P11274 BCR Homo sapiens Human PF09036 PF00168 PF19057 PF00620 PF00621 7.5 Kd ChEMBL
Q96PY6 NEK1 Homo sapiens Human PF00069 6.4 Kd ChEMBL
P07947 YES1 Homo sapiens Human PF07714 PF00017 PF00018 6.4 Kd ChEMBL
Q6ZSR9 Homo sapiens Human PF15282 6.1 Kd ChEMBL
P00519 ABL1 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 6.0 Kd ChEMBL
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P09619 PDGFRB Platelet-derived growth factor receptor beta modulator targets
P35968 KDR Vascular endothelial growth factor receptor 2 modulator targets